ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

Toon Van Gorp, David Cibula, Weiguo Lv, Floor Backes, Fırat Ortaç, K. Hasegawa, Kristina Lindemann, Antonella Savarese, Annouschka Laenen, Y.M. Kim, Lisa M. Bodnar, M-P Barretina-Ginesta, L. Gilbert, Bhavana Pothuri, Xiaojun Chen, Marcelo B.S. Flores, Tally Levy, N. Colombo, Christos Papadimitriou, Tommy Buchanan, L.C. Hanker, Gemma Eminowicz, L Rob, D. Black, Jasmine Lichfield, Gen Lin, Robert Orlowski, Stephen J. O’Keefe, Alain Lortholary, Brian M. Slomovitz